Erik Hegedus

Quilvest Asset Management SA (France) (Quilvest AM France) is the France-based asset management arm of Quilvest Asset Management SA, ultimately owned by Quilvest SA in Luxembourg. The firm was founded in 1993 and formerly known as Quilvest Gestion SA. Headquartered in Paris, Quilvest AM France manages funds and traditional asset management mandates for insurance companies, pension funds, banks, asset management companies and high-net worth individuals.

Oddo BHF SCA (Broker) is the securities brokerage division of Oddo BHF SCA, a financial services company headquartered in Paris, France. The firm provides equity brokerage services to various investors.

Oddo BHF Asset Management SAS (Oddo BHF AM) is an investment adviser founded in 1978 and is headquartered in Paris, France. The firm is a subsidiary of Oddo BHF SCA. Oddo BHF AM provides asset management and financial advisory services to domestic and international private clients, companies, institutional investors, and IFAs.

Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets.

Natixis SA (Broker) is the securities brokerage division of Natixis SA (EPA: KN), a corporate and investment bank headquartered in Paris, France. They are ultimately owned by BCPE SA. The firm provides full spectrum of broking services to various investors.

Bazarchic SA operates as an online shopping platform. It provides local and international clothing line for children, men and women. The firms offers decorations, accessories, jewelry, beauty and wellness, gastronomy related, gadgets, and other technologies. The company was founded by Liberty Verny on April 13, 2006 and is headquartered in Gennevilliers, France.

Germitec SA engages in the research, design, and marketing of medical hygiene systems. It develops Antigermix, which is used in disinfecting heat-sensitive medical instruments. The company was founded in 2005 and is headquartered in Ivry-sur-Seine, France.

UroMems SASdesigns and develops implantable medical devices. Its product is an active implantable medical device which compensates for sphincter insufficiency with the help of a MyoElectroMechanical System. The company was founded by Hamid Lamraoui in 2011 and is headquartered in Grenoble, France.

Patrival SA is an independent asset management firm headquartered in Wasquehal, France. The firm was founded in 1989 and is wholly owned by its officers. Patrival manages individuals and corporate client’s assets through several private mandates and mutual funds.

GSD Gestion SA is an independent asset management firm headquartered in Paris, France. The firm was founded by Jacques Gautier in 1992 and manages the financial assets of companies and individuals through its collective and private management.

Edmond de Rothschild Asset Management SA (EDRAM) is the asset management subsidiary of Edmond de Rothschild (France) SA, itself a subsidiary of Edmond de Rothschild SA in France. The firm was founded in 1985 and previously known as Gestion Saint Honoré. Headquartered in Paris, EDRAM is a multi-specialist expert in managing equities, corporate debt, asset allocation and sovereign debt, quantitative management, infrastructure debt and overlay and benefits from the stable and independent family shareholding structure of their parent company. They are a socially responsible investor which aims to integrate environmental, social and governance factors in an investment approach that adds value in these areas.

Takara Bio Europe AB is a provider of stem cell derived products and technologies which will drive unprecedented innovation in drug discovery and regenerative medicine today and in the future. The company was first in the world to bring to the market human embryonic stem (hES) cell-derived hepatocytes and cardiomyocytes for use as drug discovery tools. Cellartis is also the single commercial source of ethically derived hES cell lines and has developed cell lines for a range of uses. This hES cell technology platform offers a path to tools and regenerative medicine discoveries of the future. The company was founded in 2001 and is headquartered in Gothenburg, Sweden.

Palatine Asset Management SA (PAM) is a mutual fund management firm headquartered in Paris, France. The firm is a subsidiary of Banque Palatine SA, ultimately held by BPCE SA. PAM was founded in 1989 and manages monetary, bonds, fixed-income, and mutual funds for institutional investors, individuals, and companies.

Exane SA (Broker) (Exane) is the brokerage division of Exane SA, itself a subsidiary of Verner Investissements SAS in France. Established in 2004 as a joint venture between BNP Paribas and Verner Investissements, the firm is based in Paris and specializes in European equity research and broking activities. Exane has research centers in Paris and London which are supported by a team of economists and strategists.

CYTOO SA operates as a contract research organization which develops physiological cell-based assays. It focuses on developing, manufacturing, and commercializing new technologies for cell analysis for life sciences research community. The company has offices in Bethesda and Grenoble. The company was founded by François Chatelain, Alexandra Fuchs and Jacques Lewiner in 2008 and is headquartered in Grenoble, France.

France Biotech Association is an independent association founded in 1997 that brings together healthtech entrepreneurs and their expert partners. The non-profit company is based in Paris, France. The association actively contributes to meeting the many challenges of the healthtech industry, such as companies' financing, innovation-related taxes, regulatory and market access related issues. It offers concrete competition and solutions through its commissions and working groups to help startups and SMEs become international leaders capable of rapidly developing and bringing innovative solutions to patients. The French company was founded by Philippe Pouletty, Pascal Brandys, Denis J. Lucquin.

Mexbrain SAS is a French company that specializes in increasing the efficiency of treatment by combining the best of both worlds. The company is based in Fontaines-Saint-Martin, France. Mexbrain invites interested parties to contact them for any questions or investment opportunities. However, Thomas Brichart has been the CEO since incorporation.

Clevexel Pharma SAS manufactures as well as distributes pharmaceutical products. It engages in biotechnological research. The company was founded by Christian Bloy, Xiuping Wang-Zhang and Laurent Benel in 2012 and is headquartered in Paris, France.

Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France.

NG Biotech SAS is a French family-owned company founded in 2012 by a pioneer of the rapid test industry. The private company is based in Guipry-Messac, France. The company designs and manufactures innovative in vitro diagnostic tools suitable for decision making in medical emergencies, in the laboratory, and at the bedside. NG Biotech's innovation capabilities are powered by an expert R&D team backed by public-private scientific collaborations. The company proposes rapid tests in three main areas\: antimicrobial resistance, infectious disease (including COVID-19 tests), and women's health (blood pregnancy self-tests). NG Biotech's products are available in more than 70 countries, including the USA. The CEO is Milovan Stankov-Pugès.

Scipio Bioscience SAS operates as a biotechnology company. It provides a novel sample preparation solution for single-cell studies, in the form of benchtop kits, for use in sequencing applications in clinical and basic research, in particular transcriptomics. The company was founded by Pierre Walrafen and Stuart Edelstein on August 2, 2017 and is headquartered in Paris, France.

Keranova SA designs and develops surgical equipment for various ophthalmologic indications that involve the anterior segment of the eye. The company was founded by Fabrizio Romano on September 4, 2015 and is headquartered in Saint-Etienne, France.